Skip to main content

Small molecule 2′-deoxycytidine differentiates human umbilical cord-derived MSCs into cardiac progenitors in vitro and their in vivo xeno-transplantation improves cardiac function

Molecular and Cellular Biochemistry volume 470, pages 99–113 (2020)Cite this article

Abstract

Small molecules are widely used to induce stem cell differentiation. 2′-deoxycytidine (2-DC) belongs to the cytidine family. It stimulates the expression of cardiac-specific genes and proteins, and directs mesenchymal stem cells towards cardiomyogenic differentiation. We aim to investigate the role of 2-DC-treated human umbilical cord mesenchymal stem cells (UC-MSCs) into myogenic lineage and explore their application in regeneration of infarcted myocardium. UC-MSCs were treated with 5, 10, 20, and 40 µM 2-DC following optimization by cytotoxicity analysis. Rat model of myocardial infarction (MI) was induced by ligating left anterior descending coronary artery. Normal, and 2-DC treated UC-MSCs were transplanted in the left ventricular wall immediately after ligation. Echocardiographic measurements were performed to assess cardiac function. Tissue architecture of the myocardium was examined by histological analysis to determine fate of the transplanted cells. MSCs were successfully isolated from human umbilical cord tissue. 2-DC treatment did not produce any significant cytotoxic effect in UC-MSCs at all concentrations. qPCR analysis of treated UC-MSCs showed induction of myogenic differentiation, which is more pronounced at 20 μM concentration. Fluorescently labeled 2-DC-treated UC-MSCs showed significant (**P < 0.01) homing in the infarcted myocardium as compared to normal UC-MSCs. Hearts transplanted with 2-DC-treated UC-MSCs significantly (***P < 0.001) improved the cardiac systolic and diastolic functions and pumping ability as compared to normal UC-MSCs and MI groups. Fibrotic area and left ventricular wall thickness were significantly improved (***P < 0.001) in 2-DC-treated group as compared to normal UC-MSCs. Immunohistochemical staining showed co-localization of fluorescently labeled cells and patches of differentiated myocytes which were stained for cardiac proteins in the infarct zone implying that the treated UC-MSCs regenerated cardiomyocytes. We report for the first time that 2-DC induces cardiac differentiation in UC-MSCs. Transplanted cells differentiated into functional cardiomyocytes and significantly improved cardiac performance. These pre-differentiated cardiac progenitors showed better survival, homing, and distribution in the infarcted zone. 2-DC treated cells not only improved cardiac function, but also restored tissue homeostasis, suggesting a better therapeutic option for the regeneration of cardiac tissue in the clinical setup.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

References

  1. McNamara K, Alzubaidi H, Jackson JK (2019) Cardiovascular disease as a leading cause of death: how are pharmacists getting involved? Integr Pharm Res Pract. https://doi.org/10.2147/iprp.s133088

    Article  Google Scholar 

  2. Ohira T, Iso H (2013) Cardiovascular disease epidemiology in Asia: an overview. Circ J 77:1646–1652. https://doi.org/10.1253/circj.CJ-13-0702

    Article  PubMed  Google Scholar 

  3. Broughton KM, Wang BJ, Firouzi F et al (2018) Mechanisms of cardiac repair and regeneration. Circ Res. https://doi.org/10.1161/CIRCRESAHA.117.312586

    Article  PubMed  PubMed Central  Google Scholar 

  4. Talman V, Ruskoaho H (2016) Cardiac fibrosis in myocardial infarction: from repair and remodeling to regeneration. Cell Tissue Res. https://doi.org/10.1007/s00441-016-2431-9

    Article  PubMed  PubMed Central  Google Scholar 

  5. Liang C, Wang K, Li Q et al (2019) Influence of the distribution of fibrosis within an area of myocardial infarction on wave propagation in ventricular tissue. Sci Rep. https://doi.org/10.1038/s41598-019-50478-5

    Article  PubMed  PubMed Central  Google Scholar 

  6. StJohnSutton MG, Sharpe N (2000) Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation. https://doi.org/10.1161/01.cir.101.25.2981

    Article  Google Scholar 

  7. Hsich EM (2016) Matching the market for heart transplantation. Circ Hear Fail. https://doi.org/10.1161/CIRCHEARTFAILURE.115.002679

    Article  Google Scholar 

  8. Lazaros G, Oikonomou E, Tousoulis D (2017) Established and novel treatment options in acute myocarditis, with or without heart failure. Expert Rev Cardiovasc Ther. https://doi.org/10.1080/14779072.2017.1262764

    Article  PubMed  Google Scholar 

  9. Romagnuolo R, Masoudpour H, Porta-Sánchez A et al (2019) Human embryonic stem cell-derived cardiomyocytes regenerate the infarcted pig heart but induce ventricular tachyarrhythmias. Stem Cell Rep. https://doi.org/10.1016/j.stemcr.2019.04.005

    Article  Google Scholar 

  10. Dixit P, Katare R (2015) Challenges in identifying the best source of stem cells for cardiac regeneration therapy. Stem Cell Res Ther. https://doi.org/10.1186/s13287-015-0010-8

    Article  PubMed  PubMed Central  Google Scholar 

  11. Ghafarzadeh M, Namdari M, Eatemadi A (2016) Stem cell therapies for congenital heart disease. Biomed Pharmacother. https://doi.org/10.1016/j.biopha.2016.10.055

    Article  PubMed  Google Scholar 

  12. Lalu MM, Mazzarello S, Zlepnig J et al (2018) Safety and efficacy of adult stem cell therapy for acute myocardial infarction and ischemic heart failure (safecell heart): a systematic review and meta-analysis. Stem Cells Transl Med. https://doi.org/10.1002/sctm.18-0120

    Article  PubMed  PubMed Central  Google Scholar 

  13. Jeffries MA (2018) Epigenetic editing: How cutting-edge targeted epigenetic modification might provide novel avenues for autoimmune disease therapy. Clin Immunol. https://doi.org/10.1016/j.clim.2018.02.001

    Article  PubMed  PubMed Central  Google Scholar 

  14. Ramos MP, Wijetunga NA, McLellan AS et al (2015) DNA demethylation by 5-aza-2′-deoxycytidine is imprinted, targeted to euchromatin, and has limited transcriptional consequences. Epigenet Chromatin. https://doi.org/10.1186/s13072-015-0004-x

    Article  Google Scholar 

  15. Soler-Botija C, Forcales SV, Bayés Genís A (2019) Spotlight on epigenetic reprogramming in cardiac regeneration. Semin Cell Dev Biol. https://doi.org/10.1016/j.semcdb.2019.04.009

    Article  PubMed  Google Scholar 

  16. Khan I, Ali A, Akhter MA et al (2016) Preconditioning of mesenchymal stem cells with 2,4-dinitrophenol improves cardiac function in infarcted rats. Life Sci 162:60–69. https://doi.org/10.1016/j.lfs.2016.08.014

    CAS  Article  PubMed  Google Scholar 

  17. Khan I, Ali A, Akhter MA et al (2017) Epac-Rap1-activated mesenchymal stem cells improve cardiac function in rat model of myocardial infarction. Cardiovasc Ther. https://doi.org/10.1111/1755-5922.12248

    Article  PubMed  Google Scholar 

  18. Beeravolu N, Brougham J, Khan I et al (2018) Human umbilical cord derivatives regenerate intervertebral disc. J Tissue Eng Regen Med 12:e579–e591. https://doi.org/10.1002/term.2330

    CAS  Article  PubMed  Google Scholar 

  19. Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. https://doi.org/10.1080/14653240600855905

    Article  PubMed  Google Scholar 

  20. Feng S, Jacobsen SE, Reik W (2010) Epigenetic reprogramming in plant and animal development. Science 330:622–627. https://doi.org/10.1126/science.1190614

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  21. Yoon BS, Yoo SJ, Lee JE et al (2006) Enhanced differentiation of human embryonic stem cells into cardiomyocytes by combining hanging drop culture and 5-azacytidine treatment. Differentiation. https://doi.org/10.1111/j.1432-0436.2006.00063.x

    Article  PubMed  Google Scholar 

  22. Banerjee S, Bacanamwo M (2010) DNA methyltransferase inhibition induces mouse embryonic stem cell differentiation into endothelial cells. Exp Cell Res. https://doi.org/10.1016/j.yexcr.2009.08.011

    Article  PubMed  Google Scholar 

  23. Choi SC, Yoon J, Shim WJ et al (2004) 5-Azacytidine induces cardiac differentiation of P19 embryonic stem cells. Exp Mol Med. https://doi.org/10.1038/emm.2004.66

    Article  PubMed  Google Scholar 

  24. Planat-Bénard V, Menard C, André M et al (2004) Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res. https://doi.org/10.1161/01.RES.0000109792.43271.47

    Article  PubMed  Google Scholar 

  25. Oka T, Maillet M, Watt AJ et al (2006) Cardiac-specific deletion of gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ Res. https://doi.org/10.1161/01.RES.0000215985.18538.c4

    Article  PubMed  PubMed Central  Google Scholar 

  26. Li H, Zuo S, Pasha Z et al (2011) GATA-4 promotes myocardial transdifferentiation of mesenchymal stromal cells via up-regulating IGFBP-4. Cytotherapy. https://doi.org/10.3109/14653249.2011.597380

    Article  PubMed  PubMed Central  Google Scholar 

  27. Shirinsky VP, Khapchaev AY, Stepanova OV (2008) Molecular mechanisms of cardiomyogenesis and the prospects for cardiomyocyte regeneration in cardiac failure. Mol Biol. https://doi.org/10.1134/S0026893308050130

    Article  Google Scholar 

  28. Somekawa S, Fukuhara S, Nakaoka Y et al (2005) Enhanced functional gap junction neoformation by protein kinase A-dependent and Epac-dependent signals downstream of cAMP in cardiac myocytes. Circ Res. https://doi.org/10.1161/01.RES.0000183880.49270.f9

    Article  PubMed  Google Scholar 

  29. Khanabdali R, Saadat A, Fazilah M et al (2016) Promoting effect of small molecules in cardiomyogenic and neurogenic differentiation of rat bone marrow-derived mesenchymal stem cells. Drug Des Devel Ther 10:81–91. https://doi.org/10.2147/DDDT.S89658

    CAS  Article  PubMed  Google Scholar 

  30. Gao Q, Guo M, Jiang X et al (2014) A cocktail method for promoting cardiomyocyte differentiation from bone marrow-derived mesenchymal stem cells. Stem Cells Int. https://doi.org/10.1155/2014/162024

    Article  PubMed  PubMed Central  Google Scholar 

  31. Wei JN, Cai F, Wang F et al (2016) Transplantation of CXCR4 Overexpressed Mesenchymal Stem Cells Augments Regeneration in Degenerated Intervertebral Discs. DNA Cell Biol. https://doi.org/10.1089/dna.2015.3118

    Article  PubMed  Google Scholar 

  32. Song H, Chang W, Song BW, Hwang KC (2012) Specific differentiation of mesenchymal stem cells by small molecules. Am J Stem Cells 1:22–30

    CAS  PubMed  Google Scholar 

  33. Haneef K, Ali A, Khan I et al (2018) Role of interleukin-7 in fusion of rat bone marrow mesenchymal stem cells with cardiomyocytes in vitro and improvement of cardiac function in vivo. Cardiovasc Ther. https://doi.org/10.1111/1755-5922.12479

    Article  PubMed  Google Scholar 

  34. Caplan AI, Dennis JE (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem. https://doi.org/10.1002/jcb.20886

    Article  PubMed  Google Scholar 

  35. Rocha V, Wagner JE, Sobocinski KA et al (2000) Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med. https://doi.org/10.1056/NEJM200006223422501

    Article  PubMed  Google Scholar 

  36. Hatlapatka T, Moretti P, Lavrentieva A et al (2011) Optimization of culture conditions for the expansion of umbilical cord-derived mesenchymal stem or stromal cell-like cells using xeno-free culture conditions. Tissue Eng Part C Methods. https://doi.org/10.1089/ten.tec.2010.0406

    Article  PubMed  Google Scholar 

  37. Ennis J, Götherström C, Le Blanc K, Davies JE (2008) In vitro immunologic properties of human umbilical cord perivascular cells. Cytotherapy. https://doi.org/10.1080/14653240801891667

    Article  PubMed  Google Scholar 

  38. Weiss ML, Anderson C, Medicetty S et al (2008) Immune properties of human umbilical cord Wharton’s Jelly-derived cells. Stem Cells. https://doi.org/10.1634/stemcells.2007-1028

    Article  PubMed  Google Scholar 

  39. Yoo KH, Jang IK, Lee MW et al (2009) Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol. https://doi.org/10.1016/j.cellimm.2009.06.010

    Article  PubMed  Google Scholar 

  40. Azari MF, Mathias L, Ozturk E et al (2010) Mesenchymal stem cells for treatment of CNS injury. Curr Neuropharmacol. https://doi.org/10.2174/157015910793358204

    Article  PubMed  PubMed Central  Google Scholar 

  41. Sancricca C (2010) Mesenchymal stromal cells from human perinatal tissues: from biology to cell therapy. World J Stem Cells. https://doi.org/10.4252/wjsc.v2.i4.81

    Article  PubMed  PubMed Central  Google Scholar 

  42. Yang CC, Shih YH, Ko MH et al (2008) Transplantation of human umbilical mesenchymal stem cells from Wharton’s jelly after complete transection of the rat spinal cord. PLoS ONE. https://doi.org/10.1371/journal.pone.0003336

    Article  PubMed  PubMed Central  Google Scholar 

  43. Fu Y-S, Cheng Y-C, Lin M-YA et al (2006) Conversion of human umbilical cord mesenchymal stem cells in Wharton’s Jelly to dopaminergic neurons in vitro: potential therapeutic application for parkinsonism. Stem Cells. https://doi.org/10.1634/stemcells.2005-0053

    Article  PubMed  Google Scholar 

  44. Xiong N, Zhang Z, Huang J et al (2011) VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinsons disease. Gene Ther. https://doi.org/10.1038/gt.2010.152

    Article  PubMed  Google Scholar 

  45. Rasmussen JG, Frøbert O, Holst-Hansen C et al (2014) Comparison of human adipose-derived stem cells and bone marrow-derived stem cells in a myocardial infarction model. Cell Transplant. https://doi.org/10.3727/096368912X659871

    Article  PubMed  Google Scholar 

  46. Flynn A, Chen X, O’Connell E, O’Brien T (2012) A comparison of the efficacy of transplantation of bone marrow-derived mesenchymal stem cells and unrestricted somatic stem cells on outcome after acute myocardial infarction. Stem Cell Res Ther. https://doi.org/10.1186/scrt127

    Article  PubMed  PubMed Central  Google Scholar 

  47. Gahremanpour A, Vela D, Zheng Y et al (2013) Xenotransplantation of human unrestricted somatic stem cells in a pig model of acute myocardial infarction. Xenotransplantation. https://doi.org/10.1111/xen.12026

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, 75270, Pakistan

    Syeda Roohina Ali, Waqas Ahmad, Asmat Salim & Irfan Khan

  2. Dow University of Health Sciences, Ojha Campus, Gulzar-e-Hijri, Suparco Road, KDA Scheme-33, Karachi, Pakistan

    Nadia Naeem

Authors
  1. Syeda Roohina Ali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Waqas Ahmad
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nadia Naeem
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Asmat Salim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Irfan Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Irfan Khan.

Ethics declarations

Conflict of interest

Authors declare that there is no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ali, S.R., Ahmad, W., Naeem, N. et al. Small molecule 2′-deoxycytidine differentiates human umbilical cord-derived MSCs into cardiac progenitors in vitro and their in vivo xeno-transplantation improves cardiac function. Mol Cell Biochem 470, 99–113 (2020). https://doi.org/10.1007/s11010-020-03750-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-020-03750-6

Keywords

  • Mesenchymal stem cells
  • 2-Deoxycytidine
  • Cardiac function
  • Myocardial infarction
  • Regeneration